Bayer | BAYN - Des Atouts

Prix De L'Action
39.83
Variation Quotidienne
0.45 1.14%
Mensuellement
-1.91%
Annuel
85.92%
Q2 Prévisions
37.14




Des Atouts Changement Date
Air Liquide EUR 51.91B 2.58B 2025-12
Akzo Nobel EUR 13.95B 55M 2025-12
Alcon AG USD 31.56B 31M 2025-12
Amarin USD 670.78M 10.96M 2025-12
Arkema EUR 14.24B 53M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
BASF EUR 76.17B 267M 2025-12
Bayer EUR 104.54B 331M 2025-12
Beiersdorf EUR 12.76B 166M 2025-12
Corteva USD 42.85B 647M 2025-12
Covestro EUR 13.47B 245M 2025-12
Essilor EUR 63.9B 1.97B 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Fresenius Medical Care EUR 31B 115.33M 2025-12
Genmab DKK 12.87B 5.85B 2025-12
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Henkel EUR 32.53B 258M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Johnson Matthey GBP 5.83B 362M 2025-12
Linde USD 86.82B 824M 2025-12
Lonza CHF 18.97B 164M 2025-12
Merck EUR 51.53B 600M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Nutrien USD 52.3B 475M 2025-12
Philips EUR 26.94B 605M 2025-12
PPG Industries USD 22.1B 46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
SAP EUR 70.36B 1.97B 2025-12
Solvay EUR 6.15B 173M 2025-12
UCB EUR 18.16B 971M 2025-12
Umicore EUR 9.46B 865.5M 2025-12
Vinci EUR 130.45B 954M 2025-06